Evidence map›Paper›PMID 41768395›Full record

ReviewInternational journal of nanomedicine2026

Ferroptosis-Like Death: An Emerging Innovative Antibacterial Strategy.

Cheng Luo, Jialin Chen, Qifei Duan, Haibo Zhao, Nanyan Fu, Qin Deng, Yan Li

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cheng LuoSchool of Basic Medical Sciences, Yichun University, Yichun, Jiangxi, People's Republic of China.ORCID 0000-0003-2193-3670
Jialin ChenSchool of Basic Medical Sciences, Yichun University, Yichun, Jiangxi, People's Republic of China.
Qifei DuanSchool of Basic Medical Sciences, Yichun University, Yichun, Jiangxi, People's Republic of China.
Haibo ZhaoSchool of Basic Medical Sciences, Yichun University, Yichun, Jiangxi, People's Republic of China.
Nanyan FuSchool of Basic Medical Sciences, Yichun University, Yichun, Jiangxi, People's Republic of China.
Qin DengSchool of Basic Medical Sciences, Yichun University, Yichun, Jiangxi, People's Republic of China.
Yan LiSchool of Basic Medical Sciences, Yichun University, Yichun, Jiangxi, People's Republic of China.ORCID 0000-0002-7257-7859

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing global crisis of antibiotic resistance underscores the imperative for innovative antibacterial strategies that transcend conventional mechanisms. Ferroptosis, an iron-dependent form of regulated cell death characterized by lethal lipid peroxidation, is a promising therapeutic approach. This review systematically explores ferroptosis-like death as an emerging antibacterial paradigm. The core mechanism involves exogenous interventions that result in intracellular iron overload, the incorporation of polyunsaturated fatty acids (PUFAs), and the disruption of bacterial antioxidant defenses. A comprehensive evaluation of three key strategies is provided: host-directed approach, in which immune cells are programmed to eliminate intracellular pathogens; small molecule-induced pathway, in which iron agents, PUFAs, and others are used to directly trigger bacterial death; and nanomaterial-mediated precision therapy, in which functionalized nanosystems are employed for synergistic and intelligent targeting. Despite the challenges in mechanistic understanding and biosafety, future advancements through multiomics, intelligent nanosystems, and synergistic cell death pathways are anticipated to propel this field. This strategy indicates a possible transformation in anti-infective therapy from broad-spectrum killing to precision regulation. This shift offers a potentially effective solution to address drug-resistant bacterial infections.

Indexed as

Anti-Bacterial AgentsBacterial InfectionsFerroptosisAnimalsDrug Resistance, BacterialFatty Acids, UnsaturatedHost-Directed TherapyHumansIronLipid PeroxidationNanomedicineReactive Oxygen SpeciesAnti-Bacterial AgentsFatty Acids, UnsaturatedIronReactive Oxygen Speciesantibiotic resistanceferroptosis-like deathlipid peroxidationnanomedicinereactive oxygen species

Identifiers

PMID41768395
PMCPMC12949569

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.